Skip to main content
Cellbion Co., Ltd logo

Cellbion Co., Ltd — Investor Relations & Filings

Ticker · 308430 ISIN · KR7308430008 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2025-02-28 Proxy Solicitation & In…
Country KR South Korea
Listing KO 308430

About Cellbion Co., Ltd

http://www.cellbion.co.kr

Cellbion Co., Ltd. is a company engaged in the research, development, and commercialization of radiopharmaceuticals. It specializes in Radioligand Therapy (RLT), developing both therapeutic and diagnostic agents to address unmet medical needs, primarily in oncology. The company's pipeline features innovative treatments, including antibody-based approaches and radioactive probes for medical imaging. A key therapeutic candidate in its portfolio is Lu-177-DGUL. Cellbion's focus is on advancing the field of nuclear medicine through novel drug development.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for the 15th Annual General Meeting of Cellbion. It contains the meeting agenda, details on voting procedures, director activity reports, and financial statements. This type of document is standard for proxy solicitation and shareholder information materials provided prior to an AGM.
2025-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Cellbion) announcing a significant change (over 30%) in revenue or profit/loss structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report preliminary financial results before the final audit is completed. Since it provides specific financial highlights and performance metrics rather than just an announcement of a report's availability, it falls under the 'Earnings Release' category. FY 2024
2025-01-31 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure period for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal regulatory notice of the procedural steps for the meeting. Given it is a standard regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2024-12-12 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Cellbion' (주)셀비온, covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business operations, management discussions, and corporate governance details, which is characteristic of a formal quarterly financial filing submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). 9M 2024
2024-11-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). This document details the change in share ownership by a specific executive (Park Jae-min) of the company Cellbion. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2024-11-11 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition and disposal of shares by Samho Green Investment and its special related parties in the company 'Selbion'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels that cross reporting thresholds.
2024-10-23 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.